Bioheng Therapeutics
Biotechnology Research • 
New Jersey, United States • 11-20 Employees
Company overview
| Headquarters | New Jersey, United States |
| Phone number | +14008288076 |
| Website | |
| NAICS | 541714 |
| Keywords | 细胞治疗 And 生物科技 |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Key Contacts at Bioheng Therapeutics
Di Yang
Senior Director Of Corporate Development
Jung Hsuan Chen
Director Process Development
Ming Gao
Associate Director Clinical Operations
Mingxi Chen
Associate Director Of Vector Group
Yanbo Liu
Associate Director Regulatory Affairs
Wengang Ge
Senior Medical Director
Yali Zhou
Director Of R&D
Bioheng Therapeutics Email Formats
Bioheng Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@bioheng.com), used 91.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@bioheng.com | 91.7% |
{first initial}.{last name} | j.doe@bioheng.com | 8.3% |
About Bioheng Therapeutics
Bioheng Therapeutics is a clinical-stage company focused on allogeneic "off-the-shelf" universal CAR-T therapies. Founded in 2017, we aim to develop the world’s leading allogeneic cell therapy platforms and products to address some of the most challenging unmet needs. In February 2025, our CD7-targeted UCAR-T, CTD402, received Investigational New Drug (IND) approval from the U.S. FDA for the treatment of T-ALL/LBL.This product is based on Bioheng's novel and proprietary UCAR-T technology platform - ANSWER®. We are progressing the global clinical trial for this promising pipeline. Built upon our ANSWER® platform, we are actively developing multiple UCAR-T pipelines. These programs have demonstrated robust and extended allogeneic CAR-T persistence, showing strong potential in both oncology and autoimmune indications. We are always striving to meet these unmet needs.
Bioheng Therapeutics revenue & valuation
| Annual revenue | $1,539,990 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Bioheng Therapeutics has 9 employees across 7 departments.
Departments
Number of employees
Funding Data
Bioheng Therapeutics has never raised funding before.
Bioheng Therapeutics Tech Stack
Discover the technologies and tools that power Bioheng Therapeutics's digital infrastructure, from frameworks to analytics platforms.
PaaS
JavaScript libraries
Analytics
Reverse proxies
JavaScript frameworks
CDN
JavaScript frameworks
JavaScript libraries
UI frameworks
Web servers
Germany
Saudi Arabia
Sweden
Australia
DenmarkFrequently asked questions
4.8
40,000 users
